Results 21 to 30 of about 1,207,383 (287)

Liver resection for colorectal metastases [PDF]

Annals of The Royal College of Surgeons of England, 2003
Colorectal cancer is the second commonest malignancy in the UK. Metastases to the liver occur in greater than 50% of patients and remain the biggest determinant of outcome in these patients. Liver resection is a safe procedure that achieves good long-term survival, but surgery has traditionally been limited to select groups of patients.
S R, Bramhall, U, Gur, C, Coldham, B K, Gunson, A D, Mayer, P, McMaster, D, Candinas, J A C, Buckels, D F, Mirza   +8 more
openaire   +2 more sources

What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up [PDF]

, 2010
Background: During the last two decades, resection of colorectal liver metastases (CLM) in selected patients has become the standard of care, with 5-year survival rates of 25-58%.
Parks, Rowan W.; id_orcid, Aldrighetti, Luca, Garden, O. James, Parks, Rowan W., Bodingbauer, Martin, Wigmore, Stephen J., Castillo, Federico, Ferla, Gianfranco, Pulitano, Carlo   +8 more
core   +1 more source

Surgical treatment of colorectal cancer liver metastases

Acta Medica Lituanica, 2011
Background. Colorectal cancer is a major health problem. Approximately 25% of the patients present with liver metastases at initial diagnosis and more than 50% develop metastases in the course of illness.
Dainius ŠIMČIKAS, Marius PAŠKONIS, Vitalijus SOKOLOVAS, Eligijus POŠKUS, Kęstutis STRUPAS   +4 more
doaj   +1 more source

First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI) [PDF]

, 2012
The objective of this pilot clinical study was to assess the safety, technical feasibility, pharmacokinetic (PK) profile and tumour response of DC Bead™ with irinotecan (DEBIRI™) delivered by intra-arterial embolisation for the treatment of metastatic ...
Hammerstingl, Renate Maria, Mack, Martin G., Gallus, Christof, Eichler, Katrin, Gruber-Rouh, Tatjana, Vogl, Thomas J., Zangos, Stephan   +6 more
core   +1 more source

Autofluorescence-Raman Spectroscopy for Ex Vivo Mapping Colorectal Liver Metastases and Liver Tissue [PDF]

, 2023
Introduction: Identifying colorectal liver metastases (CRLM) during liver resection could assist in achieving clear surgical margins, which is an important prognostic variable for both disease-free and overall survival.
Dusanjh, Palminder Kaur, Harwood, Andrew, Mukherjee, Abhik, Dhanwant Gomez, Palminder Kaur Dusanjh, Abhik Mukherjee, Boitor, Radu, Christopher Corden, Ioan Notingher, Radu Boitor, Corden, Christopher, Notingher, Ioan, Gomez, Dhanwant, Andrew Harwood   +13 more
core   +1 more source

Total-liver-volume perfusion CT using 3-D image fusion to improve detection and characterization of liver metastases [PDF]

, 2008
The purpose of this study was to evaluate the feasibility of a totalliver- volume perfusion CT (CTP) technique for the detection and characterization of livermetastases.
Cornelis van Kuijk, van Waesberghe, Jan, Meijer, Sybren, Weide, Lineke van der, Sybren Meijer, van Kuijk, C., van den Tol, Petrousjka, Lineke van der Weide, van den Tol, M.P., van der Weide, L., Meijer, S., van der Weide, Lineke, Meijerink, Martijn, Martijn R. Meijerink, Jan Hein T. M. van Waesberghe, Meijerink, M.R., van Waesberghe, J.H.T.M., Kuijk, Cornelis van, Petrousjka van den Tol, Waesberghe, Jan van, Tol, Petrousjka van den   +20 more
core   +1 more source

Can localised 19F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response? [PDF]

, 2010
Background 5-Fluorouracil remains widely used in colorectal cancer treatment more than 40 years after its development. 19F magnetic resonance spectroscopy can be used in vivo to measure 5FU’s half-life and metabolism to cytotoxic fluoronucleotides ...
Griffiths, John R., Ladroue, Christophe, Lofts, F, Lofts, Fiona, Griffiths, JR, John R. Griffiths, Marion Stubbs, Stubbs, Marion, Franklyn A. Howe, Fiona Lofts, McIntyre, DJ, Ladroue, C, Howe, FA, Howe, Franklyn A., McIntyre, Dominick J. O., Dominick J. O. McIntyre, Stubbs, M, Christophe Ladroue   +17 more
core   +1 more source

Surgical treatment of colorectal cancer metastases [PDF]

Scripta Medica, 2020
Background/Aim: Colorectal metastatic liver tumours are the most common secondary liver tumours. During the life of patients with colorectal tumorous, this liver metastases will develop either synchronously or metachronously in half of the patients ...
Škrbić Velimir, Simatović Milan, Janjić Goran, Šaran Dalibor   +3 more
doaj  

Surgery for Colorectal Liver Metastases [PDF]

Digestive Surgery, 2013
Half of all patients with colorectal cancer develop metastatic disease. The liver is the principal site for metastases, and surgical resection is the only modality that offers the potential for long-term cure. Appropriate patient selection for surgery and improvements in perioperative care have resulted in low morbidity and mortality rates, resulting ...
S J, McNally, R W, Parks
openaire   +2 more sources

MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal Carcinoma. [PDF]

PLoS ONE, 2016
OBJECTIVE:Metastasis is the major cause of death in colorectal cancer patients. Expression of certain miRNAs in the primary tumors has been shown to be associated with progression of colorectal cancer and the initiation of metastasis.
Fabian Feiersinger, Elke Nolte, Sven Wach, Tilman T Rau, Nikolaos Vassos, Carol Geppert, Andreas Konrad, Susanne Merkel, Helge Taubert, Michael Stürzl, Roland S Croner   +10 more
doaj   +1 more source